MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Companies: Acquiring (M&A)
Grifols, S.A. (NASDAQ:GRFS)*
Organization & Developments: Grifols
Parents
Grifols, S.A. (NASDAQ:GRFS)*
Children
*Barcelona-based Grifols is Europe’s biggest maker of blood-plasma products but its $1.3 billion in revenue ranks a distant fourth among such companies worldwide
*Spanish multinational pharmaceutical and chemical company Grifols
2013: Novartis to unload blood transfusion Dx arm for $1.7B (2013)
2018: FDA panel rejects Aradigm/Grifols’ inhaled antibiotic
2023: Grifols: Upside After A Smashing Q1 2023 - I Say 'Buy'_ seekingalpha.com
2024: Grifols faces old issues as Brookfield walks away from takeover bid_ FirstWord
2024: Grifols: Here Is Why It's Still A 'Buy' Even If Price Goes Down
2024: Grifols: More Attractive Than In A Very Long Time_ seekingalpha.com
2024: Grifols: Q4 Was Positive, Still Too Many Question Marks
2025: Grifols: If This Works Out, It Has Massive Upside
2025: Grifols: Looking At The Longer-Term 2025-2027 Upside After No Sale
2025: MJFF awards $21.5 million for 10-year Parkinson’s biomarker study
Jumps
Finance & Acquisitions: Grifols
Key People: Grifols